Next due
7 OCTTDS / TCS deposit · Deducted in Sep 2026due today 11 OCTGSTR-1 · Outward supplies · Sep 2026in 4 days 15 OCTPF & ESI · Contributions · Sep 2026in 8 days 20 OCTGSTR-3B · Summary return · Sep 2026in 13 days 21 OCTTax Audit Report · Form 3CA/3CB · AY 2026-27 · extended from 30 Sepin 14 days 30 OCTAOC-4 · Financial statements · FY 2025-26in 23 days 21 NOVITR filing · Audit cases · AY 2026-27 · extended from 31 Octin 45 days 29 NOVMGT-7 / 7A · Annual return · FY 2025-26in 53 days
All due dates

Reply to Drug Inspector Show Cause Notice — Draft

Complete guide to drug inspector under Drugs and Cosmetics Act, 1940. Process, compliance, penalties, latest amendments. Updated March 2026.

Published
Updated
Reading time
6 min
Views
51
Questions
7 answered
  • Expert Reviewed
  • Medium Complexity
Topic
Drugs & Cosmetics
Published
March 23, 2026
Last updated
Oct 6, 2026
Reading time
6 min
0:00
Last updated: October 2026Verified against: Government sources

Overview

This article provides a detailed explanation of Reply to Drug Inspector Show Cause Notice under the Drugs and Cosmetics Act, 1940 and applicable Rules/Regulations. All amendments, notifications, and official circulars up to March 2026 are incorporated.

Relevant provisions: Section 22.

Why This Matters
Non-compliance with drug inspector provisions can result in penalties, prosecution, seizure of goods, cancellation of licenses, and business disruption. Understanding these requirements is essential for lawful operation in India.

Legal Framework

Section 22 of the Drugs and Cosmetics Act, 1940 establishes the regulatory framework for drug inspector. The provisions cover: (a) scope and applicability, (b) licensing/registration requirements, (c) compliance conditions, (d) inspection and enforcement, and (e) penalties for violation.

Who Must Comply?

Entity TypeApplicable?Key Requirement
ManufacturerYesLicense/Registration mandatory before operations
ImporterYesImport license + compliance with Indian standards
Dealer/DistributorYesTrade license + labelling compliance
E-Commerce SellerYesSame compliance as physical sellers + digital display rules
RetailerYesVerification of goods, display of mandatory information
ExporterPartiallyExport goods may have different standards; check destination country

Detailed Explanation with Examples

Example 1: A manufacturer in Faridabad must obtain the required license before commencing production. The application is filed with the prescribed authority along with all required documents. Non-compliance can result in seizure of goods and penalties.

Example 2: An importer bringing goods into India must ensure compliance with Indian standards and obtain necessary registrations/approvals before customs clearance. Goods not meeting standards may be rejected at the port or destroyed.

Example 3: An e-commerce seller listing products online must ensure all mandatory declarations (MRP, net quantity, manufacturer details, country of origin) are displayed on the product listing, just as they would appear on physical packaging.

Compliance Advice
For drug inspector, maintain a compliance file with all licenses, test reports, and certificates. Conduct periodic internal audits. our regulatory compliance team handles end-to-end compliance.
Quick recapKey facts & short answers

Key Facts About Reply to Drug Inspector

  • Applies in: All states across India, under the relevant central law.
  • Mode: Mostly online via the official government portal.
  • Typical timeline: Ranges from a few days to a few weeks depending on the case.
  • Non-compliance: May attract penalties, interest or late fees.
  • Expert help: TaxClue completes Reply to Drug Inspector end to end for you.

What is Reply to Drug Inspector?

Reply to Drug Inspector is an important compliance and legal topic for businesses and individuals in India. This guide explains its meaning, applicability and key requirements in simple language so you can understand and stay fully compliant.

Who needs to know about Reply to Drug Inspector?

Business owners, startups, professionals, and taxpayers dealing with Reply to Drug Inspector should understand the applicable rules. Requirements can vary by turnover, entity type and activity, so it is best to confirm your specific case before proceeding.

A supplier's licence is part of your own compliance — ask for a copy and check its validity.

— TaxClue Product Compliance Desk

Reply to Drug Inspector: a key compliance topic in Indian tax and corporate law that businesses and individuals must understand to remain compliant.

READY DRAFTReply to Drug Inspector Show Cause Notice

A reply to a Show Cause Notice issued by a Drug Inspector/Licensing Authority under the Drugs and Cosmetics Act, 1940 (proposing suspension/cancellation of a drug licence or prosecution), rebutting the allegations and seeking that the notice be withdrawn.

[Name of Licensee / Firm]
[Full Address of Premises]
Drug Licence No.: [Form 20/21/25/28 No.]
Date: [DD/MM/YYYY]

To,
The Drugs Inspector / Licensing Authority,
[Office of the Drugs Control Administration],
[State / District], [Address].

Ref: Reply to Show Cause Notice No. [___] dated [DD/MM/YYYY]

Subject: Reply to Show Cause Notice issued under Rule 66 / Section 22
         of the Drugs and Cosmetics Act, 1940 read with the Drugs and
         Cosmetics Rules, 1945, proposing [suspension / cancellation of
         Drug Licence No. [___] / action for the alleged contravention].

Respected Sir / Madam,

1. We are in receipt of the Show Cause Notice bearing No. [___] dated
   [DD/MM/YYYY] ("the Notice"), issued in respect of our licensed
   premises "[Name]" operating under Drug Licence No. [___].

2. We respectfully deny each allegation in the Notice except as
   specifically admitted, and submit our reply as under.

3. BACKGROUND: We hold a valid drug licence and have been carrying on
   the business of [manufacture / wholesale / retail] of drugs since
   [year] under the supervision of our Competent/Registered Pharmacist
   Shri/Smt. [Name], Registration No. [___].

4. REPLY TO THE ALLEGATIONS:

   (a) Allegation: [e.g. sample declared "Not of Standard Quality"
       vide Government Analyst report No. [___]].
       Reply: [We received the said report only on [Date]; we hereby
       exercise our right under Section 25(3)/(4) of the Act to have
       the sample tested by the Central Drugs Laboratory. We further
       state that the batch was stored/handled as per label conditions
       and the NSQ, if any, is not attributable to us as a
       dealer/manufacturer for the reasons stated in [___].]

   (b) Allegation: [e.g. absence of qualified pharmacist / sale without
       prescription / cold-chain lapse].
       Reply: [The alleged lapse is denied / has been rectified vide
       [action] on [Date]; the pharmacist was present as per attendance
       record enclosed.]

   (c) Allegation: [e.g. record / storage deficiency under Schedule N /
       Schedule H].
       Reply: [Corrective action taken; records now maintained as
       required; supporting documents enclosed.]

5. That the alleged contravention, even if presumed without admission,
   is technical and inadvertent, involves no risk to public health, and
   has since been remedied. There is thus no ground for
   suspension/cancellation of the licence or for prosecution.

6. That any adverse order would gravely prejudice our lawful business
   and the livelihood of our staff, and would be disproportionate.

7. PRAYER: We most respectfully request your good office to:
     (i)  drop the Show Cause Notice and proceedings thereunder;
     (ii) grant us an opportunity of personal hearing before passing
          any order, in accordance with natural justice; and
     (iii) take our reply and compliance on record.

Enclosures:
   1. Copy of the Show Cause Notice dated [DD/MM/YYYY].
   2. Copy of valid Drug Licence and Pharmacist registration.
   3. Government Analyst report / correspondence (if any).
   4. Purchase / sale records / cold-chain logs, as applicable.
   5. Corrective-action documents / photographs.

Thanking you,

Yours faithfully,
For [Name of Licensee / Firm],

____________________________
([Name])
[Proprietor / Partner / Director / Authorised Signatory]
Mobile: [___]   Email: [___]
▸ How to use & important notes
  • Show Cause / suspension action against a drug licence is taken under Rule 66 (retail/wholesale) or Rule 85 (manufacture) of the Drugs & Cosmetics Rules, 1945 read with the Act — reply within the time given and always ask for a personal hearing.
  • Where a Government Analyst report is relied upon, invoke the statutory right under Section 25(3)/(4) to have the sample tested by the Central Drugs Laboratory within 28 days of receiving the report — this can be decisive.
  • Attach the pharmacist registration, purchase/sale records and cold-chain logs as relevant; keep an acknowledged copy.
  • If the licence is still suspended/cancelled, an appeal lies to the State Government under Section 33/ the Rules within the prescribed period.

Disclaimer: This is a general-purpose template for reference only. Facts, figures, stamp duty and clauses vary with your situation and state law — have it reviewed before use. Need this professionally drafted, stamped and filed? Talk to a TaxClue expert.

Related Services & Guides

Was this article helpful?
About the author
13,350 articles
Vikas Sharma Verified expert Tax & Compliance Expert

Experienced in company registration, GST, trademark, and compliance. Helping Indian businesses stay compliant.

Last reviewed: Live

Disclaimer: This article is for general informational purposes only and does not constitute professional tax, legal or financial advice. Laws, rates and due dates change and can vary by individual case — always verify with the relevant government source (e.g. mca.gov.in, incometax.gov.in) or consult a qualified professional before acting. TaxClue accepts no liability for decisions taken based on this content.

People also ask

Questions, answered

Short, direct answers to the 7 questions readers ask most on this topic.

Reply to Drug Inspector is an important compliance and legal topic for businesses and individuals in India. This guide explains its meaning, applicability and key requirements in simple language so you can understand and stay fully compliant.

Business owners, startups, professionals, and taxpayers dealing with Reply to Drug Inspector should understand the applicable rules. Requirements can vary by turnover, entity type and activity, so it is best to confirm your specific case before proceeding.

Typical documents include PAN, identity and address proof, business registration proof, and any category-specific forms. The exact checklist depends on your situation — TaxClue experts can prepare the correct set for Reply to Drug Inspector and help you avoid rejections.

The process generally involves preparing documents, filing the correct form on the relevant government portal, paying applicable fees, and tracking status until approval. Following the right sequence for Reply to Drug Inspector helps avoid delays and penalties.

Yes. Late or non-compliance related to Reply to Drug Inspector can attract penalties, interest or late fees, and some filings have strict due dates. Staying on schedule protects you from avoidable costs — TaxClue sends timely reminders.

In most cases yes, Reply to Drug Inspector can be handled online through the official government portal. TaxClue can complete the end-to-end process for you digitally, so you don't have to visit any office.

TaxClue's CA, CS and legal experts handle Reply to Drug Inspector end to end — eligibility check, documentation, filing, and follow-up. Refer to Income Tax Department for official rules, and contact TaxClue for hands-on, affordable assistance.